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Background
Influenza activity in Portugal
has been monitored since
1953 at the National Institute of
Health. Clinical and virological
data is analysed and Influenza-
like Illness (ILI) incidence rates
are estimated weekly.
Information is forwarded to
National Health Authorities,
contributing for the
management of the disease.
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The National Influenza
Surveillance Programme
collects and integrates
information generated through
2 sentinel surveillance
structures, the General
Practitioner’s Sentinel Network
(since 1990) and the Network
of Emergency Units (since
1999). The Programme also
integrates the information from
the Portuguese component of
the IMOVE project. Here we
provide a snapshot of the
influenza activity in Portugal
during the 2014/2015 winter,
based on the information
generated through the
Portuguese Influenza
Surveillance System.
Materials and Methods
ILI cases were reported to the
National Influenza Reference
Laboratory and to the
Epidemiology Department of
Results
During the 2014/2015 winter, between
September 2014 and May 2015, 903
nasopharyngeal swabs from ILI cases
were sent to the Portuguese NIC
(Figure 1 and 2). Influenza activity was
high with an epidemic period of 8
weeks (from week 1 to 8/2015) with a
max. 148 ILI cases / 105 inhabitants in
week 4/2015 (Figure 2). Influenza
viruses were detected in 498 (55%) ILI
cases: 328 (36%) influenza
B/Yamagata viruses, 149 (17%)
influenza A(H3) viruses and 21 (2%)
pandemic influenza A(H1) viruses
(Figure 1).
A(H3) positive cases were recorded in
higher percentage in children (0 to 4
years: 40.0% and 5 to 14 years:
41.5%) and in adults over 65 years
(36.2%), as seen in Figure 3.
The antigenic and genetic analysis of
circulating influenza A(H3) and B virus
Figure 2 – Weekly distribution of ILI incidence rates and influenza positive and negative cases, season 2014/2015.
Figure 1 – Influenza laboratory diagnosis in ILI cases from the
2014/2015 season.
Figure 3 – Distribution of influenza positive cases by age group, season 2014/2015..
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the National Institute of Health,
in the context of the National
Influenza Surveillance
Programme, from week
38/2014 through week
20/2015. The intensity and
duration of the epidemic
periods were described based
on the weekly incidence rates
for ILI. Nasopharyngeal swabs
were collected for virological
characterisation of influenza
viruses circulating during this
period. The detection of
influenza viruses was
performed by real time RT-
PCR. Influenza virus culture
was performed in MDCK cells
and a sample of isolates was
taken for sequence analysis of
the HA1 gene segment.
showed differences regarding
2014/2015 influenza vaccine strains
(Figure 4 and Table I). Most A(H3)
viruses belonged to subgroup 3C.2a,
antigenically different from vaccine
strain A/Texas/50/2012. Although
genetically all Influenza B belong to
B/Phuket/3073/2013 group,
antigenically 21% of them were low
reactors to this antiserum (Figure 4).
A(H1)pdm09 viruses were similar to
the vaccine A/California/7/2009 strain.
In general, the detected influenza
viruses were similar to those
recommended strains for next winter`s
vaccine 2015/2016.
Conclusions
• Influenza activity was high. B/Yamagata viruses were dominant during most weeks of the 2014/2015 flu
season, but co-circulated with influenza A(H3). Sporadic cases of A(H1)pdm09 were detected.
• Most influenza A and B viruses were antigenically distinct from the 2014/2015 vaccine strains.
• Influenza A(H3) detections reached the highest percentages in the age groups of the children and elderly.
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Figure 4 – Antigenic characterisation of influenza A and B viral strains, isolated during the 2014/2015 season.
A/California = A/California/7/2009-like; A/Switz = A/Switzerland/9715293/2013-like;
B/Phuket = B/Phuket/3073/2013; B/Mass = B/Massachusetts/2/2012.
Table I – Genetic characterisation of influenza A and B viral strains, isolated during the 2014/2015 season.
Subtype/Lineage Phylogenetic group N. of viruses
A/Hong Kong/5659/2012 (group 6A) 0
A(H1)pdm09 A/South Africa/3626/2013 (group 6B) 10
A/Dakar/04/2014 (group 6C) 0
A/Texas/50/2012 (subgroup 3C.1) 0
A(H3) A/Samara/73/2013 (subgroup 3C.3) 18
A/Hong Kong/5738/2014 (subgroup 3C.2a) 37
B/Yamagata B/Massachusetts/2/2012 (group 2) 0
B/Phuket/3073/2013 (group 3) 56
Total of sequenced viruses 121
